The Orzel installation comes at a crucial time for the ultra-rare disorder, known to afflict a few thousand people worldwide. When Eastlack died at age 39 in 1973, FOP research was nonexistent. Now, it has spawned an industry. Several potential therapies are in clinical trials, and dozens of companies are racing to exploit new insights that could transform the treatment not only of FOP, but of head trauma, fractures, bone malformations, osteoporosis, joint replacements, and much more.